title: Ex vivo reversal of chemoresistance by tariquidar (XR9576).
authors.affiliation: Translational Oncology Research Centre, Department of Histopathology, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK.
authors.forename: Federica
authors.initials: F
authors.lastname: Di Nicolantonio
authors.forename: Louise A
authors.initials: LA
authors.lastname: Knight
authors.forename: Sharon
authors.initials: S
authors.lastname: Glaysher
authors.forename: Pauline A
authors.initials: PA
authors.lastname: Whitehouse
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Mercer
authors.forename: Sanjay
authors.initials: S
authors.lastname: Sharma
authors.forename: Lisa
authors.initials: L
authors.lastname: Mills
authors.forename: Alison
authors.initials: A
authors.lastname: Prin
authors.forename: Penny
authors.initials: P
authors.lastname: Johnson
authors.forename: Peter A
authors.initials: PA
authors.lastname: Charlton
authors.forename: David
authors.initials: D
authors.lastname: Norris
authors.forename: Ian A
authors.initials: IA
authors.lastname: Cree
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm / Q000187:drug effects* / Q000502:physiology; D004354:Drug Screening Assays, Antitumor; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D011804:Quinolines / Q000494:pharmacology* / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D014407:Tumor Cells, Cultured
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D011804:Quinolines; C402343:tariquidar